5-Keto-3-cyano-2,4-diaminothiophenes as selective maternal embryonic leucine zipper kinase inhibitorsNicolas Boutard, Piotr Kowalczyk, Anna Cierpich et al.|Bioorganic & Medicinal Chemistry Letters|2018Cited by 8
Abstract 4231: Preclinical candidate RVU305, an MTA-cooperative PRMT5 inhibitor, shows activity in MTAP-deleted tumors resistant to immune checkpoint treatmentAnna Bartosik, Krzysztof Brzózka, Adam Radzimierski et al.|Cancer Research|2025Cited by 1